Rheonix receives EUA for rapid molecular COVID-19 test
May 1, 2020—Rheonix announced it has received FDA emergency use authorization for the Rheonix COVID-19 MDx Assay.
Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Hologic to launch second assay for novel coronavirus
April 30, 2020—Hologic plans to launch an Aptima molecular assay to detect the SARS-CoV-2 virus that will run on its Panther system, which provides initial results in about three hours and processes more than 1,000 coronavirus tests in a 24-hour period. The company expects to begin distributing next week a research use only version of its Aptima SARS-CoV-2 test to hospital, public health, and reference laboratories certified under CLIA to perform high-complexity tests and plans to provide its laboratory customers
Ortho launches second COVID-19 antibody test
April 27, 2020—Ortho Clinical Diagnostics announced the FDA granted emergency use authorization to its second COVID-19 antibody test, the Vitros Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test.
FDA approves Cobas HPV test for Cobas 6800/8800 systems
April 24, 2020—Roche announced FDA approval for the Cobas HPV test for use on the fully automated, high-throughput Cobas 6800/8800 systems.
ELITechGroup MDx distributes EUA kit
April 23, 2020—ELITechGroup MDx and its Korean partner, Osang Healthcare, announced that the FDA has issued emergency use authorization for its SARS-CoV-2 virus test for use in the United States.
Randox unveils molecular controls for SARS-CoV-2
April 23, 2020—Randox Laboratories has developed Randox Qnostics SARS-CoV-2 whole pathogen quality controls designed for laboratories managing COVID-19 testing to help ensure the accuracy and reliability of molecular assays used in the testing of suspected coronavirus samples.
FDA clears i-Stat CG4+, Chem8+
April 22, 2020—Abbott’s i-Stat CG4+ and Chem8+ cartridges have received FDA clearance.
ARUP Labs rolls out COVID-19 antibody testing
April 21, 2020—ARUP Laboratories will begin rolling out COVID-19 antibody testing nationwide by the end of this week.
Nova webinar on COVID-19 bedside glucose management
April 20, 2020—Nova Biomedical announced a webinar, titled “COVID-19 Bedside Glucose Management: Risk of Ascorbic Acid and Hematocrit Interference,” to help inform and support health care workers treating COVID-19 patients. Led by Charbel Abou-Diwan, PhD, director of Nova Biomedical’s medical and scientific affairs, the webinar examines the risk of inaccurate glucose meter results due to interference from ascorbic acid and anemia. The webinar will be delivered on Thursday, April 30, at 2 PM; Thursday, May 28, at 1 PM; and
MedTest Dx FDA-approved quantitative test for G6PD
April 20, 2020—MedTest Dx announced the availability of its Pointe Scientific–branded assay for the highly sensitive quantification of G6PD in whole blood.